Stratos Investment Management LLC grew its holdings in The Procter & Gamble Company (NYSE:PG – Free Report) by 3.6% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 36,733 shares of the company’s stock after acquiring an additional 1,290 shares during the period. Stratos Investment Management LLC’s holdings in Procter & Gamble were worth $6,362,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Wulff Hansen & CO. boosted its position in shares of Procter & Gamble by 16,292.0% in the second quarter. Wulff Hansen & CO. now owns 3,675,902 shares of the company’s stock valued at $606,230,000 after acquiring an additional 3,653,477 shares during the period. TD Asset Management Inc boosted its holdings in Procter & Gamble by 114.9% in the 1st quarter. TD Asset Management Inc now owns 3,568,671 shares of the company’s stock valued at $579,017,000 after purchasing an additional 1,907,716 shares during the period. AMF Tjanstepension AB grew its position in shares of Procter & Gamble by 416.1% during the 3rd quarter. AMF Tjanstepension AB now owns 1,818,490 shares of the company’s stock worth $315,016,000 after purchasing an additional 1,466,115 shares in the last quarter. Swedbank AB bought a new position in shares of Procter & Gamble during the first quarter worth approximately $233,788,000. Finally, Ilex Capital Partners UK LLP acquired a new stake in shares of Procter & Gamble in the first quarter valued at approximately $228,212,000. 65.77% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
A number of equities analysts have commented on the company. DA Davidson restated a “neutral” rating and set a $159.00 price objective on shares of Procter & Gamble in a research note on Tuesday. TD Cowen started coverage on shares of Procter & Gamble in a research note on Tuesday, July 23rd. They set a “buy” rating and a $189.00 price objective on the stock. Evercore ISI upped their price target on shares of Procter & Gamble from $177.00 to $183.00 and gave the stock an “outperform” rating in a report on Thursday, July 18th. Royal Bank of Canada lifted their price objective on shares of Procter & Gamble from $157.00 to $164.00 and gave the company a “sector perform” rating in a research note on Wednesday, July 31st. Finally, Citigroup lifted their price target on Procter & Gamble from $177.00 to $190.00 and gave the company a “buy” rating in a research note on Wednesday, July 10th. Nine research analysts have rated the stock with a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $176.21.
Procter & Gamble Trading Down 0.6 %
NYSE:PG opened at $171.28 on Friday. The stock has a market capitalization of $404.23 billion, a price-to-earnings ratio of 28.45, a PEG ratio of 3.74 and a beta of 0.41. The firm has a fifty day simple moving average of $171.77 and a two-hundred day simple moving average of $167.11. The company has a current ratio of 0.73, a quick ratio of 0.53 and a debt-to-equity ratio of 0.51. The Procter & Gamble Company has a 12 month low of $142.50 and a 12 month high of $177.94.
Procter & Gamble (NYSE:PG – Get Free Report) last released its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, beating analysts’ consensus estimates of $1.90 by $0.03. The firm had revenue of $21.74 billion for the quarter, compared to analyst estimates of $21.99 billion. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. The business’s quarterly revenue was down .6% compared to the same quarter last year. During the same period last year, the firm earned $1.83 earnings per share. Analysts expect that The Procter & Gamble Company will post 6.97 EPS for the current fiscal year.
Procter & Gamble Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be given a $1.0065 dividend. This represents a $4.03 dividend on an annualized basis and a yield of 2.35%. The ex-dividend date is Friday, October 18th. Procter & Gamble’s payout ratio is 66.94%.
Insider Activity at Procter & Gamble
In other news, CFO Andre Schulten sold 13,041 shares of the firm’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the completion of the sale, the chief financial officer now owns 37,208 shares in the company, valued at $6,325,360. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In other Procter & Gamble news, CFO Andre Schulten sold 13,041 shares of the business’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the sale, the chief financial officer now owns 37,208 shares of the company’s stock, valued at $6,325,360. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Jon R. Moeller sold 7,007 shares of Procter & Gamble stock in a transaction on Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total value of $1,202,751.55. Following the completion of the transaction, the chief executive officer now owns 269,172 shares of the company’s stock, valued at approximately $46,203,373.80. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 383,194 shares of company stock valued at $65,140,718. 0.18% of the stock is owned by insiders.
About Procter & Gamble
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
See Also
- Five stocks we like better than Procter & Gamble
- Which Wall Street Analysts are the Most Accurate?
- Survey Reveals: America’s Most Coveted Businesses in 2024
- How is Compound Interest Calculated?
- Top 3 Stocks to Play Oil’s Potential Comeback Rally
- What Are Dividend Challengers?
- Analysts See Growth in CrowdStrike Stock Despite July Setback
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.